Nandrolone Phenylpropionate

History of creation:

Nandrolone Phenylpropionate (Durabolin or Nandrolone F) is a steroid with pronounced anabolic and moderate androgenic activity. It was released in the 60s of the last century and has proven itself in the treatment of metabolic disorders, severe burns, muscular dystrophy, lack of growth hormone.

The drug exists in injectable and oral forms. During its use in professional sports has acquired the status of a fairly "soft" steroid, perfect for gaining muscle mass and use in the pre-competition period.

Unlike DECA, its molecule contains shorter ester chains, so that the active substance Nandrolone Phenylpropionate penetrates the bloodstream faster. The effect of Durinabol on the body does not last 2 weeks, as is the case with Decanoate, and 3-4 days.

The effect of the use:

Excluding different rates of entry into the blood, the agent is similar to the effect of Nandrolone Decanoate. The low degree of aromatization (transition to female hormones) and androgenic activity cause a relatively small frequency of adverse reactions. The anabolic action of the drug is enough to increase muscle mass to 7-8 kg per course without a pronounced phenomenon of rollback.

Main effects of Nandrolone Phenylpropionate:

Acceleration of protein biosynthesis, consolidation of positive nitrogen balance; growth of muscle mass, strengthening of its relief; stimulation of collagen production; protection of ligaments and bones; increase of activity, endurance and strength indicators; strengthening of immunity.

The course Nandrolone Phenylpropionate:

A single dosage is selected individually, based on the expected results, physiological characteristics, and in the course of treatment usually does not exceed 400-500 mg.the Injection is carried out from 2 times a week intramuscularly deep. Duration of administration - from 4 to 8 weeks.

To increase the effectiveness of the tool is combined with other steroids (one or two). Nandrolone Phenylpropionate combines well with Turinabol, Winstrol, Testosterone. The drug is contraindicated for use at the age of 18 years, with ischemia, malignant neoplasms, diseases of the prostate and liver, renal failure.